Franziska E. Müller

Dr. Franziska E. Müller

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 May 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AKAnna Konopka
Anna Konopka
AZAndre Zeug
Andre Zeug
ASAnna Skupien
Anna Skupien
BKBeata Kaza
Beata Kaza
FMFranziska E. Müller
Franziska E. Müller
JDJoanna Dzwonek
Joanna Dzwonek
Communication of cells with their extracellular environment is crucial to fulfill their function in physiological and pathophysiological conditions. The literature data provide evidence that such a communication is also important in case of astrocytes. Mechanisms that contribute to the interaction between astrocytes and extracellular matrix (ECM) proteins are still poorly understood. Hyaluronan is the main component of ECM in the brain, where its major receptor protein CD44 is expressed by a subset of astrocytes. Considering the fact that functions of astrocytes are tightly coupled with changes in their morphology (e.g.: glutamate clearance in the synaptic cleft, migration, astrogliosis), we investigated the influence of hyaluronan cleavage by hyaluronidase, knockdown of CD44 by specific shRNA and CD44 overexpression on astrocyte morphology. Our results show that hyaluronidase treatment, as well as knockdown of CD44, in astrocytes result in a “stellate”-like morphology, whereas overexpression of CD44 causes an increase in cell body size and changes the shape of astrocytes into flattened cells. Moreover, as a dynamic reorganization of the actin cytoskeleton is supposed to be responsible for morphological changes of cells, and this reorganization is controlled by small GTPases of the Rho family, we hypothesized that GTPase Rac1 acts as a downstream effector for hyaluronan and CD44 in astrocytes. We used FRET-based biosensor and a dominant negative mutant of Rac1 to investigate the involvement of Rac1 activity in hyaluronidase- and CD44-dependent morphological changes of astrocytes. Both, hyaluronidase treatment and knockdown of CD44, enhances Rac1 activity while overexpression of CD44 reduces the activity state in astrocytes. Furthermore, morphological changes were blocked by specific inhibition of Rac1 activity. These findings indicate for the first time that regulation of Rac1 activity is responsible for hyaluronidase and CD44-driven morphological changes of astrocytes.

1 January 2018 in Brain Research Bulletin
Verified
Journal Article
Closed access
AZAndre Zeug
Andre Zeug
FMFranziska E. Müller
Franziska E. Müller
SAStefanie Anders
Stefanie Anders
MHMichel K Herde
Michel K Herde
DMDaniel Minge
Daniel Minge
Christian HennebergerChristian Henneberger
Christian Henneberger

23 December 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MMMarta Maglione
Marta Maglione
GKGaga Kochlamazashvili
Gaga Kochlamazashvili
Tobias EisenbergTobias Eisenberg
Tobias Eisenberg
Bence RaczBence Racz
Bence Racz
EMEva Michael
Eva Michael
SSStephan J. Sigrist
Stephan J. Sigrist
Aging is associated with functional alterations of synapses thought to contribute to age-dependent memory impairment (AMI). While therapeutic avenues to protect from AMI are largely elusive, supplementation of spermidine, a polyamine normally declining with age, has been shown to restore defective proteostasis and to protect from AMI in Drosophila. Here we demonstrate that dietary spermidine protects from age-related synaptic alterations at hippocampal mossy fiber (MF)-CA3 synapses and prevents the aging-induced loss of neuronal mitochondria. Dietary spermidine rescued age-dependent decreases in synaptic vesicle density and largely restored defective presynaptic MF-CA3 long-term potentiation (LTP) at MF-CA3 synapses (MF-CA3) in aged animals. In contrast, spermidine failed to protect CA3-CA1 hippocampal synapses characterized by postsynaptic LTP from age-related changes in function and morphology. Our data demonstrate that dietary spermidine attenuates age-associated deterioration of MF-CA3 synaptic transmission and plasticity. These findings provide a physiological and molecular basis for the future therapeutic usage of spermidine.

2 August 2022 in Cells
Verified
Journal Article
Open access
PDF file
TITatiana Ilchibaeva
Tatiana Ilchibaeva
ATAnton Tsybko
Anton Tsybko
AZAndre Zeug
Andre Zeug
FMFranziska E. Müller
Franziska E. Müller
DGDaria Guseva
Daria Guseva
VNVladimir Naumenko
Vladimir Naumenko
Serotonin receptor 5-HT2A and tropomyosin receptor kinase B (TrkB) strongly contribute to neuroplasticity regulation and are implicated in numerous neuronal disorders. Here, we demonstrate a physical interaction between 5-HT2A and TrkB in vitro and in vivo using co-immunoprecipitation and biophysical and biochemical approaches. Heterodimerization decreased TrkB autophosphorylation, preventing its activation with agonist 7,8-DHF, even with low 5-HT2A receptor expression. A blockade of 5-HT2A receptor with the preferential antagonist ketanserin prevented the receptor-mediated downregulation of TrkB phosphorylation without restoring the TrkB response to its agonist 7,8-DHF in vitro. In adult mice, intraperitoneal ketanserin injection increased basal TrkB phosphorylation in the frontal cortex and hippocampus, which is in accordance with our findings demonstrating the prevalence of 5-HT2A–TrkB heteroreceptor complexes in these brain regions. An expression analysis revealed strong developmental regulation of 5-HT2A and TrkB expressions in the cortex, hippocampus, and especially the striatum, demonstrating that the balance between TrkB and 5-HT2A may shift in certain brain regions during postnatal development. Our data reveal the functional role of 5-HT2A–TrkB receptor heterodimerization and suggest that the regulated expression of 5-HT2A and TrkB is a molecular mechanism for the brain-region-specific modulation of TrkB functions during development and under pathophysiological conditions.

6 November 2020 in Glia
Verified
Journal Article
Open access
PDF file
FMFranziska E. Müller
Franziska E. Müller
SSSophie K. Schade
Sophie K. Schade
VCVolodymyr Cherkas
Volodymyr Cherkas
LSLaura Stopper
Laura Stopper
BBBjörn Breithausen
Björn Breithausen
AZAndre Zeug
Andre Zeug
Astrocytes are an important component of the multipartite synapse and crucial for proper neuronal network function. Although small GTPases of the Rho family are powerful regulators of cellular morphology, the signaling modules of Rho‐mediated pathways in astrocytes remain enigmatic. Here we demonstrated that the serotonin receptor 4 (5‐HT4R) is expressed in hippocampal astrocytes, both in vitro and in vivo. Through fluorescence microscopy, we established that 5‐HT4R activation triggered RhoA activity via Gα13‐mediated signaling, which boosted filamentous actin assembly, leading to morphological changes in hippocampal astrocytes. We investigated the effects of these 5‐HT4R‐mediated changes in mixed cultures and in acute slices, in which 5‐HT4R was expressed exclusively in astrocytes. In both systems, 5‐HT4R‐RhoA signaling changed glutamatergic synaptic transmission: It increased the frequency of miniature excitatory postsynaptic currents (mEPSCs) in mixed cultures and reduced the paired‐pulse‐ratio (PPR) of field excitatory postsynaptic potentials (fEPSPs) in acute slices. Overall, our present findings demonstrate that astrocytic 5‐HT4R‐Gα13‐RhoA signaling is a previously unrecognized molecular pathway involved in the functional regulation of excitatory synaptic circuits.

1 February 2021 in Progress in Neurobiology
Verified
Journal Article
Closed access
JLJosephine Labus
Josephine Labus
KRKian-Fritz Röhrs
Kian-Fritz Röhrs
JAJana Ackmann
Jana Ackmann
HVHristo Varbanov
Hristo Varbanov
FMFranziska E. Müller
Franziska E. Müller
EPEvgeni Ponimaskin
Evgeni Ponimaskin